NASDAQ:CLPT

ClearPoint Neuro - CLPT Stock Forecast, Price & News

$7.97

+0.12 (+1.53%)

(As of 03/24/2023 08:51 PM ET)

Add

Compare

Today's Range: $7.68
▼
$8.11
50-Day Range: $7.33
▼
$10.63
52-Week Range: $7.00
▼
$16.96

Volume: 24,600 shs
Average Volume: 68,865 shs
Market Capitalization: $196.14 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.00

Institutional Ownership

ClearPoint Neuro MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 75.7% Upside
$14.00 Price Target
Short Interest: Bearish
2.93% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.64 out of 5 stars

Medical Sector

884th out of 1,005 stocks

Surgical & Medical Instruments Industry

88th out of 102 stocks

3.5

Analyst's Opinion

Consensus Rating
ClearPoint Neuro has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $14.00, ClearPoint Neuro has a forecasted upside of 75.7% from its current price of $7.97.
Amount of Analyst Coverage
ClearPoint Neuro has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
2.93% of the outstanding shares of ClearPoint Neuro have been sold short.
Short Interest Ratio / Days to Cover
ClearPoint Neuro has a short interest ratio ("days to cover") of 10.3, which indicates bearish sentiment.
Change versus previous month
Short interest in ClearPoint Neuro has recently increased by 0.54%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
ClearPoint Neuro does not currently pay a dividend.
Dividend Growth
ClearPoint Neuro does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CLPT.

3.3

News and Social Media Coverage

News Sentiment
ClearPoint Neuro has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for ClearPoint Neuro this week, compared to 1 article on an average week.
Search Interest
3 people have searched for CLPT on MarketBeat in the last 30 days.
MarketBeat Follows
Only 1 people have added ClearPoint Neuro to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ClearPoint Neuro insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.94% of the stock of ClearPoint Neuro is held by insiders.
Percentage Held by Institutions
Only 15.11% of the stock of ClearPoint Neuro is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of ClearPoint Neuro is -11.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ClearPoint Neuro is -11.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ClearPoint Neuro has a P/B Ratio of 5.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About ClearPoint Neuro (NASDAQ:CLPT) Stock

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Receive CLPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter.

CLPT Stock News Headlines

March 7, 2023 | finance.yahoo.com

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2022 Earnings Call Transcript

March 1, 2023 | msn.com

ClearPoint Neuro GAAP EPS of -$0.68 beats by $0.02, revenue of $20.55M misses by $0.03M

March 27, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.

March 1, 2023 | finance.yahoo.com

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results

February 15, 2023 | finance.yahoo.com

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2022 Revenue Results March 1, 2023

January 30, 2023 | seekingalpha.com

ClearPoint Neuro Is A 'Buy' Based On Growing Revenues And Decreasing Cash Burn

January 24, 2023 | seekingalpha.com

CLPT ClearPoint Neuro, Inc.

January 11, 2023 | finance.yahoo.com

ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue

March 27, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

December 20, 2022 | finance.yahoo.com

ClearPoint Neuro Announces First Patient Enrolled in Glioblastoma Trial Using ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Sweden

November 9, 2022 | finance.yahoo.com

ClearPoint Neuro to Present at Upcoming Investor Conferences

November 8, 2022 | msn.com

ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates

November 8, 2022 | finance.yahoo.com

ClearPoint Neuro Reports Third Quarter 2022 Results

November 8, 2022 | msn.com

ClearPoint Neuro's Earnings: A Preview

October 26, 2022 | finance.yahoo.com

ClearPoint Neuro to Announce Third Quarter 2022 Results November 8, 2022

September 25, 2022 | marketwatch.com

ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism(TM) Neuro Laser Therapy System

September 23, 2022 | markets.businessinsider.com

ClearPoint Neuro (CLPT) Gets a Buy from B.Riley Financial

September 23, 2022 | finance.yahoo.com

ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism™ Neuro Laser Therapy System

September 20, 2022 | finance.yahoo.com

FDA Approves ClearPoint Neuro's Updated Software For Guidance System For Neurological Procedures

September 20, 2022 | finance.yahoo.com

ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer

September 19, 2022 | finance.yahoo.com

ClearPoint Neuro Announces FDA Clearance for Software Version 2.1

September 19, 2022 | seekingalpha.com

ClearPoint Neuro: Continuous Great Execution

August 19, 2022 | seekingalpha.com

ClearPoint Neuro: Picks & Shovels Galore

August 10, 2022 | nasdaq.com

ClearPoint Neuro's (NASDAQ:CLPT) investors will be pleased with their incredible 724% return over the last five years

August 10, 2022 | fool.com

ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript

August 10, 2022 | nasdaq.com

ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates

August 9, 2022 | markets.businessinsider.com

ClearPoint Shares Climb as FDA Announced Clearance To Maestro Brain Model Software

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CLPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter.

CLPT Company Calendar

Last Earnings: 3/01/2023
Today: 3/26/2023
Next Earnings (Estimated): 5/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:CLPT
CUSIP: N/A
CIK: 1285550
Web: www.clearpointneuro.com
Phone: (949) 900-6833
Fax: 949-900-6834
Employees: 67
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $14.00
High Stock Price Forecast: $14.00
Low Stock Price Forecast: $14.00
Forecasted Upside/Downside: +75.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.68)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-16,430,000.00
Net Margins: -79.97%
Pretax Margin: -79.97%
Return on Equity: -39.77%
Return on Assets: -27.95%

Debt

Debt-to-Equity Ratio: 0.27
Current Ratio: 7.54
Quick Ratio: 6.17

Sales & Book Value

Annual Sales: $20.55 million
Price / Sales: 9.54
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.50 per share
Price / Book: 5.31

Miscellaneous

Outstanding Shares: 24,610,000
Free Float: 23,393,000
Market Cap: $196.14 million
Optionable: Not Optionable
Beta: 1.14

Key Executives

Joseph Michael Burnett
President, Chief Executive Officer & Director

Mazin Sabra
Chief Operating Officer

Danilo D’Alessandro
Chief Financial Officer

Chris Yelley
Vice President-Operations

Robert C. Korn
Vice President-Business Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CLPT Stock - Frequently Asked Questions

Should I buy or sell ClearPoint Neuro stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ClearPoint Neuro in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CLPT shares.
View CLPT analyst ratings or view top-rated stocks.
What is ClearPoint Neuro's stock price forecast for 2023?: 1 equities research analysts have issued 1-year price objectives for ClearPoint Neuro's stock. Their CLPT share price forecasts range from $14.00 to $14.00. On average, they predict the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 75.7% from the stock's current price.
View analysts price targets for CLPT or view top-rated stocks among Wall Street analysts.
How have CLPT shares performed in 2023?: ClearPoint Neuro's stock was trading at $8.47 on January 1st, 2023. Since then, CLPT shares have decreased by 5.9% and is now trading at $7.97.
View the best growth stocks for 2023 here.
When is ClearPoint Neuro's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our CLPT earnings forecast.
How were ClearPoint Neuro's earnings last quarter?: ClearPoint Neuro, Inc. (NASDAQ:CLPT) posted its quarterly earnings data on Wednesday, March, 1st. The company reported ($0.18) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.04. The business had revenue of $5.17 million for the quarter, compared to the consensus estimate of $5.19 million. ClearPoint Neuro had a negative net margin of 79.97% and a negative trailing twelve-month return on equity of 39.77%.
What ETF holds ClearPoint Neuro's stock ?: iShares Neuroscience and Healthcare ETF holds 3,040 shares of CLPT stock, representing 0.50% of its portfolio.

What guidance has ClearPoint Neuro issued on next quarter's earnings?: ClearPoint Neuro updated its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $25.00 million-$27.00 million, compared to the consensus revenue estimate of $25.91 million.
What is ClearPoint Neuro's stock symbol?: ClearPoint Neuro trades on the NASDAQ under the ticker symbol "CLPT."
Who are ClearPoint Neuro's major shareholders?: ClearPoint Neuro's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Taylor Frigon Capital Management LLC (0.70%), CM Management LLC (0.62%), Susquehanna International Group LLP (0.52%), Millennium Management LLC (0.48%), Sentinus LLC (0.39%) and Morgan Stanley (0.38%).
View institutional ownership trends.
How do I buy shares of ClearPoint Neuro?: Shares of CLPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ClearPoint Neuro's stock price today?: One share of CLPT stock can currently be purchased for approximately $7.97.
How much money does ClearPoint Neuro make?: ClearPoint Neuro (NASDAQ:CLPT) has a market capitalization of $196.14 million and generates $20.55 million in revenue each year. The company earns $-16,430,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis.
How can I contact ClearPoint Neuro?: ClearPoint Neuro's mailing address is 5 MUSICK, IRVINE CA, 92618. The official website for the company is www.clearpointneuro.com. The company can be reached via phone at (949) 900-6833, via email at hhurwitz@clearpointneuro.com, or via fax at 949-900-6834.

This page (NASDAQ:CLPT) was last updated on 3/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ClearPoint Neuro - CLPT Stock Forecast, Price & News

ClearPoint Neuro MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About ClearPoint Neuro (NASDAQ:CLPT) Stock

CLPT Stock News Headlines

CLPT Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

CLPT Stock - Frequently Asked Questions

Overall MarketRank^™